AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MONTELUKAST 4 Mg ;

13 registrations across 1 African market— 13 active

Markets with MONTELUKAST 4 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Delmonkast
Oral granules in sachet
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
Kast
Oral granules in sachet
🇪🇬EgyptHikma pharmaactive
Montekal 4 mg
Chewable Tablets
🇪🇬EgyptEuropean egyptian pharmaceutical industriesactive
Montasmawel 4 mg
Chewable Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Inletair
Oral Granules
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Statukast 4mg
Chewable Tablets
🇪🇬EgyptAdwiaactive
Montelosab 4 mg
Chewable Tablets
🇪🇬Egyptvercureactive
Montekal 4 mg
Chewable Tablets
🇪🇬EgyptEuropean egyptian pharmaceutical industriesactive
Montasmawel 4 mg
Chewable Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Kast
Oral granules in sachet
🇪🇬EgyptHikma pharmaactive
Delmonkast
Oral granules in sachet
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
Montelosab 4 mg
Chewable Tablets
🇪🇬Egyptvercureactive
Statukast 4mg
Chewable Tablets
🇪🇬EgyptAdwiaactive

MONTELUKAST 4 Mg ; in Africa — Regulatory Overview

MONTELUKAST 4 Mg ; is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.